Mark Eugenio is a seasoned professional in business development with extensive experience in the pharmaceutical and fine chemistry sectors. Currently serving as Sr. Director of Business Development-Drug Substance, API at Cambrex since September 2023, Mark previously held multiple leadership roles, including Vice President of Business Development at Alcami Corporation and at Avista Pharma Solutions, which is now part of Cambrex. Mark's career is marked by impactful contributions across companies like Albemarle Fine Chemistry Services, Albany Molecular Research Inc., and Cambridge Major Laboratories, focusing on driving growth and developing strategic partnerships within the industry. Mark holds a Bachelor of Science degree in Chemistry from Bridgewater State University and furthered education at the University of Massachusetts, Lowell.
This person is not in the org chart
This person is not in any teams
This person is not in any offices